Nano Daru

Nano Daru is a private Iranian pharmaceutical company focused on high-technology medicines, nanotechnology-enabled formulations, and novel drug delivery systems. The company appears to operate as both a developer and manufacturer of specialty and generic pharmaceuticals, with capabilities spanning nanoparticles, microspheres, and antibody-drug conjugates. Publicly visible products and programs include PACLINAB, a nab-paclitaxel product for metastatic cancers, EXOPIO for opioid dependence, and additional oncology and hospital products such as palbociclib capsules. Nano Daru positions itself around affordable access to innovative medicines, particularly in oncology and other unmet-need areas. Available sources indicate commercial activity in finished dosage formulations as well as an internal development pipeline.